PROGNOSTIC UTILITY OF TRIGLYCERIDE RICH LIPOPROTEINS RELATED MARKERS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE ON STATIN THERAPY

Ye-Xuan Cao,Hui Wen Zhang,Jing-Lu Jin,Hui-Hui Liu,Yan Zhang,Rui-Xia Xu,Ying Gao,Yuan-Lin Guo,Na-Qiong Wu,Cheng-Gang Zhu,Chuan-Que Cui,Geng Liu,Qian Dong,Jing Sun,Qi Hua,Yan-Fang Li,Jian-Jun Li

PROGNOSTIC UTILITY OF TRIGLYCERIDE RICH LIPOPROTEINS RELATED MARKERS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE ON STATIN THERAPY

2020

Ye-Xuan Cao
Hui Wen Zhang
Jing-Lu Jin
Hui-Hui Liu
Yan Zhang
Rui-Xia Xu
Ying Gao
Yuan-Lin Guo
Na-Qiong Wu
Cheng-Gang Zhu
Chuan-Que Cui
Geng Liu
Qian Dong
Jing Sun
Qi Hua
Yan-Fang Li
Jian-Jun Li

Triglyceride-rich lipoproteins (TRL)-related markers, containing cholesterol subset [TRL-cholesterol (TRL-C) and remnant-like lipoprotein particles cholesterol (RLP-C)] and apolipopoprotein C-III (apoC-III), were reported to be involved in atherosclerosis. This multicenter prospective cohort study

Keywords:

statin therapy
Diabetes mellitus
Cardiology
Triglyceride
Medicine
Coronary artery disease
Internal medicine
Prospective cohort study
Cholesterol
Lipoprotein
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations